Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients
- Conditions
- Parkinson's Disease (PD)BradykinesiaUpper Limb Function
- Registration Number
- NCT06641193
- Brief Summary
A randomized, double-blind, sham-controlled unicenter clinical trial was used to investigate the effectiveness and neural mechanism of high-frequency repetitive transcranial magnetic stimulation in the treatment of upper limb bradykinesia in patients with Parkinson's disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 60
- Hoehn and Yahr (HY) stage 1-2
- Able to understand and cooperate with the study
- Predominantly characterized by bradykinesia
- Onset on the left side
- Contraindications for TMS including DBS surgery, Ventriculoperitoneal shunt, etc
- Other neurological disorders
- Significant resting tremor, with MDS-UPDRS-III tremor score ≥3
- Resting threshold cannot be measured
- Received other TMS treatments within the last 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Unified Parkinson's Disease Rating Scale (MDS-UPDRS) 2 weeks and 4 weeks Change in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) total score of part III from Day 1 to 1 year. The part III of the MDS-UPDRS assess motor function in best on phase. The score range is 0-132, where a higher score means more severe motor impairment.
- Secondary Outcome Measures
Name Time Method cortical activation detected by fNIRS 2 weeks and 4 weeks Using near-infrared brain imaging systems, have patients perform finger tapping, fist clenching, and forearm rotation movements to observe brain region activation.
Trial Locations
- Locations (1)
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
🇨🇳Shanghai, China